India coronavirus vaccine market is anticipated to witness double-digit CAGR in the forecast period, FY2023-FY2027. The growth in the market can be attributed to increased demand for preventive drugs and other related products; thereby supporting the growth of the India coronavirus vaccine market in the next five years. In the end of year 2019, the outbreak of COVID-19 was observed first in Wuhan City, China. The infection later spread rapidly in other Asian countries and by March 2020, World Health Organization (WHO) declared it a global pandemic. The world observed a complete lockdown that affected end user industries including healthcare. Healthcare facilities struggled with the administration of patients and their cure while the market for almost all other products and services were shutdown. Death toll that the pandemic caused and the number of complications the virus caused in other patients gave a warning toward the severity of the concerns, driving the growth of India coronavirus vaccine market. Moreover, governmental aid toward the vaccination, availability of the vaccines systematically to all the age groups are driving the market growth. India is currently in the overdrive process of providing vaccination against COVID-19 through fast track development process. Although, more research is being conducted in order to confirm the cure of a particular virus and fight against coronavirus. Coronavirus vaccines safely deliver immunogen that is antigen specific which triggers human immune-response system Human immune-response system generates antibodies against the antigen and the B-cells are later stored as T-cells thereby creating a memory response for the viral pathogen. In case of any future infection by COVID-19 virulent, the immune system of the body responses based on the memory cell responses and fights off disease. Furthermore, research is being conducted to provide cost-effective vaccine with higher efficiency that can create most effective T-cells that will completely fight off the virus attack. Some of the top players in the India coronavirus vaccine market include Serum Institute of India Pvt. Ltd., Bharat Biotech International Ltd., Zydus Cadila Ltd., Pfizer India Ltd., Panacea Biotec Ltd., Indian Immunologicals Ltd., Mynvax Pvt. Ltd., Biological E Ltd., Hetero Biopharma Ltd., Dr Reddy’s Laboratories Ltd., among others. The companies are involving themselves into research and development for the methods of better quality, and various quality analysis tests to provide the better products.

1. MARKET INTELLIGENCE . CONSULTING
www.techsciresearch.com
INDIA CORONAVIRUS VACCINE
MARKET
FORECAST & OPPORTUNITIES
FY2017 – FY2027

2. 2
Scope of Report
Product of Interest (POI): Coronavirus Vaccine
A COVID-19 vaccine is a vaccine intended to provide acquired immunity
against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the
virus that causes coronavirus disease 2019 (COVID-19). The COVID-19
vaccines are widely celebrated for their role in reducing the spread, severity,
and death caused by COVID-19.
Market Segmentation
REGION
• South
• West
• East
• North
TYPE
• mRNA Based
• Non-Replicating Viral Vector Based
• Inactivated Vaccine
END USER
• Hospitals
• Clinics
• Research Institutes
• Others
Review Period
FY2017 – FY2020
Base Year
FY2021
Estimated Year
FY2022
Forecast Period
FY2023 – FY2027
Year Range

3. 3
© TechSci Research
S. No. Contents
1.
Product Overview (A brief description of the category and product inclusions considered under the scope
of the study to give clear picture to the client about the product of interest.)
2.
Research Methodology (A detailed methodology on how we have derived the market related information
and what are the measures that has been taken to validate the data.)
3. Impact of COVID-19 on India Coronavirus Vaccine Market
4. Executive Summary (This chapter covers summary of the complete study.)
5. Voice of Customer/Customer Insights
6.
India Coronavirus Vaccine Market Outlook, FY2017-FY2027 (This chapter includes a brief overview of
the product of interest market such as total market’s growth rate, expected growth rate, key growth levers,
leading region, top grossing product types, etc. It includes more of a qualitative information about the
market.)
6.1.
Market Size & Forecast (This chapter would include the market size i.e., the revenue generated from
the India Coronavirus Vaccine market in one year. In this case, the market size will be provided in
Value terms for historic period (FY2017-FY2020); current/base year (FY2021); estimated year
(FY2022E); and forecast (FY2023-FY2027)
6.1.1. By Value & Volume
6.2. Market Share & Forecast (The overall product of interest bifurcated/split among various segments. )
6.2.1. By Type (mRNA Based, Non-Replicating Viral Vector Based, Inactivated Vaccine)
6.2.2. By End User (Hospitals, Clinics, Research Institutes, Others)
6.2.3. By Region
6.2.3.1. By State (Top 10 States)
6.2.4. By Company (FY 2021)
6.3. Product Market Map
Table of Contents

4. 4
4
S No. Contents Page No.
7. India mRNA Based Coronavirus Vaccine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By End User
8. India Non- Replicating Viral Vector Based Coronavirus Vaccine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By End User
9. India Inactivated Coronavirus Vaccine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By End User
Table of Contents

5. 5
© TechSci Research
S. No. Contents
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Development
12. Policy & Regulatory Landscape
13. Comparative Analysis of Approved Vaccines in the India
14. Vaccination Scenario in the India
15. Analysis of Prospective Vaccines (Vaccines in Clinical Trials)
16. Import-Export Analysis
17. Pricing Analysis
18. India Economic Profile
19. Competitive Landscape
19.1. Competitive Landscape
19.2. Company Profiles (Top 10 Companies)
19.2.1. Company Details
19.2.2. Products & Services
19.2.3. Financials (As Reported)
19.2.4. Key Market Focus & Geographical Presence
19.2.5. Recent Developments
19.2.6. Key Management Personnel
Table of Contents

6. 6
© TechSci Research
S. No. Contents
20.
Strategic Recommendations (Based on the findings of the report strategic recommendations on how to
enter and expand market share)
21. About Us & Disclaimer
Table of Contents

7. RESEARCH
METHODOLOGY

8. 8
© TechSci Research
Research Methodology
 Identifying Key Opinion
Leaders
 Questionnaire Design
 In-depth Interviews
Data
Collection
Developing List
of Respondents
Formulating
Questionnaire
Market
Profiling
Data
Validation
Data
Analysis
In-depth secondary
research was conducted to
determine top players in
India coronavirus vaccine
market, overall market size
and segmental market size.
In order to conduct
industry experts’
interviews, TechSci
formulated a detailed
discussion guide.
List of industry
players and industry
specialists was
developed.
TechSci conducted
interviews with
industry experts and
industry players for
data collection and
verification.
Data obtained as a
result of primary
and secondary
research was
validated through
rigorous
triangulation.
The data was scrutinized
using MS-Excel, statistical
tools and internal
proprietary database to
obtain qualitative and
quantitative insights about
India coronavirus vaccine
market.
Data
Collection
Data Filter
& Analysis
Research &
Intelligence
Actionable
Insights
Business
Solution
Primary Research Desk Research Company Analysis
 Recent Developments
 Market Changing
Aspects/Dynamics
 Government Policies
 Conclusion
 Market Participants
 Key Strengths
 LinkedIn
 TechSci Internal
Database
 Factiva
 Hoovers
Paid Sources
 Company Websites
 Company Annual
Reports
 White Paper Study
 Financial Reports
 Investor
Presentations
 Regulatory Body
 Associations, etc.
Secondary
Research
Primary Research

9. 9
© TechSci Research
Research Methodology
Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of India coronavirus vaccine market. The team has
market, while considering the major influencing factors such as increasing use of coronavirus vaccine. The study includes market
better decisions while planning their strategy to achieve sustainability in India coronavirus vaccine market.
Methodology Followed for Calculation of Market Size:
• Market Size by Value & Volume: Market size, in terms of value & volume, for the year FY2021 was calculated based on information
collected through exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as
supplier companies, end users, industry experts and other industry participants.
• The team interviewed more than 10-20 coronavirus vaccine manufacturers, 50 – 75 major end users, 15 – 20 industry experts and
market to obtain the overall market size from FY2017 to FY2021, which was validated by the Delphi technique. Taking standard
averaged out, to arrive at the market size data during FY2017-FY2021.

10. 10
© TechSci Research
Research Methodology
• Respondents were asked about the current and future market growth rates, market shares by type, by end user, by company and by each region. Removing the outlier responses,
the geometric mean of growth estimates and supplier wise revenue shares generated across various segments were considered, to arrive at the final revenue shares. Revenue
shares generated across various segments were further triangulated from other stakeholders depending upon the segments of coronavirus vaccine.
Methodology Followed for Calculation of Market Shares:
• Market shares by type, by end user, by company and by each region were calculated based on the responses received through primary surveys with industry experts, in which the
respondents were asked about the market shares or revenue generated from various types of coronavirus vaccine. The final shares were calculated by taking the geometric mean of
the responses gathered from key opinion leaders after eliminating the outliers.
Methodology Followed for Forecasting:
• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in SPSS/Tableau Software.
• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast India coronavirus vaccine market , TechSci Research
used various forecast techniques such as:
 Moving Average
 Time Series Analysis
 Regression Analysis
 Econometric and Judgmental Analysis

11. 11
© TechSci Research
Research Methodology
TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during
short, medium and long term period to estimate the demand emanating in the market. It should be noted that the figures compiled are only for the organized market including market
share data.
Partial List of Companies Interviewed Key Secondary Sources
 Serum Institute of India (SII)
 Biological E. Limited
 Cipla Ltd (Moderna’s Vaccine)
 Bharat Biotech International Limited
 Astra Zeneca Pharma India Limited
 Panacea Biotec Ltd.
 Hetero Biopharma Ltd.
 Virchow Biotech Private Limited
 Gland Pharma Limited
 Stelis Biopharma Pvt. Ltd.
 World Bank
 TechSci Research Proprietary Database & Knowledge Repository
 Company Annual Reports
 Industry Magazines
 Industry Reports
 News Dailies
 Credible Paid Databases

12. 12
Industry Brief
Need for protection against the Coronaviridae virus and its strains is driving the growth of India coronavirus vaccine market, in the forecast period, FY2017-FY2027.
According to TechSci report on, “India Coronavirus vaccine Market By Infection Type (SARS-CoV, MERS-CoV, SARS-CoV-2) By Vaccine Type (Virus vaccine, Viral vector
vaccine, Nucleic acid vaccines, Protein based vaccine, Others) By Product Type (Monovalent Vaccine v/s Multivariant Vaccine) By Route of Administration (Oral, Intramuscular,
Intranasal) By Patient Type (Pediatric v/s Adult) By End User (Hospitals, Clinics, Research Institutes, Others) By Region, Competition Forecast & Opportunities, FY2027”, India
coronavirus vaccine market has shown promising growth in historical years until FY2020 and is expected to continue its growth in upcoming forecast years from FY2022 to
FY2027. Governmental aids to enhance the research and development of the prevention drugs and finding the solution to the fastest growing pandemic is driving the growth of
the India coronavirus vaccine market. Key players are actively involved in enhancing the quality of the drugs as well as the easier distribution of the vaccine all over the country.
The private investments are also boosting the growth of the India coronavirus vaccine market in the upcoming five years. Moreover, inorganics developments like collaborations
among the players, agreements with the distributors for the effective supply of the drugs to the end users, are major growth factors behind the impressive CAGR of India
coronavirus vaccine market.
Wuhan City, China was the firstly discovered geography where the COVID-19 virus outbreak was addressed. Within next 3 months, world health organization (WHO) confirmed
the outbreak to be a pandemic and death threat to the human population. This catastrophic pandemic has already claimed millions of lives and although the precaution measures
are widely accepted, the number of cases has not yet died. With the spur of variant strains of the virus, a new wave of infection is still suspected. This would support the market
growth since the death threat is concerning. Also, increasing healthcare expenditures is going to support the market growth, actively.
India coronavirus vaccine Market is segmented by infection type, vaccine type, product type, route of administration, patient type, end user, regional distribution, and
competitional landscape. Based on infection type the market is categorized into SARS-CoV, MERS-CoV, and SARS-CoV-2. Infections caused by SARS-CoV-2 is considered
most lethal and easily transmitted, thus can be reasoned for maximum market share because it is causing pandemic all over the world including India at a rapid pace. The
transmission is as simple as basic contact, droplet, airborne, fomite, faecal-oral, bloodborne, mother-to-child, and animal-to-human transmission. SARS-CoV is a less lethal but a
similar strain of the coronavirus, whereas MERS-CoV is specific to Middle East countries and is contagious and sometimes fatal.
Based on product type, the market is categorized into monovalent vaccine, and multivariant vaccine. Monovalent vaccines are specific antigen targeting vaccines. Whereas
multivariant vaccines target multiple antigens or here, multiple strains of the same virus making it preferable. Even in the current year 2021, country still faces the threat from the
evolving strains of the virus causing concerns toward the threatening pandemic that may reinstate the complete lockdown situation. Based on these facts, multivariant vaccines
are anticipated to dominate the market in the forecast period.
Based on route of administrations the market is further segmented into oral, intramuscular, and intranasal. Intramuscular administration through injecting the vaccines in two
stages is prevalent in the country. Therefore, intramuscular route of administration is anticipated to dominate the future market. Oral administrations may have the largest share
owing to the availability of the vaccine for infants and children. Intramuscular and intranasal administration is often painful and may cause physical irritation effects whereas oral
vaccines are completely painless and has ease of administration.
Some of the top players in the India coronavirus vaccine market are, Serum Institute of India Pvt. Ltd., Bharat Biotech International Ltd., Zydus Cadila Ltd., Pfizer India Ltd.,
Panacea Biotec Ltd., Indian Immunologicals Ltd., Mynvax Pvt. Ltd., Biological E Ltd., Hetero Biopharma Ltd., Dr Reddy’s Laboratories Ltd., among others. The companies are
involving themselves into research and development for the methods of better quality, and various quality analysis tests to provide the better products.
“India coronavirus vaccination system is following a systematic approach to administer the vaccines to all the population. Elderly, children and patient population was
administered early looking at the chances of infection to be more in them. By the end of FY2021, system allowed all the population to complete their vaccination process.
Although the number of cases has decreased significantly, the country is also struggling with new strain spread. general awareness and concerns among the population will
increase vaccination process. Moreover, west India is a promising region for the market looking at the still increasing cases of corona patients in states like Maharashtra,” said
Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

13. 13
Sample Data - Snapshot
India Coronavirus Vaccine Market Size, By Value (USD Million) & By Volume (Units), FY2017-FY2027F
5.00
6.00
7.00
8.00
9.00
10.00
11.00
12.00
13.00
14.00
15.00
10.00 20.00 30.00 40.00 50.00 60.00 70.00 80.00 90.00 100.00 110.00
FY2017 FY2021 FY2022E FY2027F
By Value (USD Million)
By Volume (Units)
CAGR BY VALUE: XX%
CAGR BY VOLUME: XX%
CAGR BY VALUE: XX%
CAGR BY VOLUME: XX%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
33%
34%
34%
34%
34%
34%
34%
34%
34%
34%
34%
34%
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022E
FY2023F
FY2024F
FY2025F
FY2026F
FY2027F
mRNA Based Non-Replicating Viral Vector Based Inactivated Vaccine
India Coronavirus Vaccine Market Share, By Type, By Value, FY2017-FY2027F
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022E
FY2023F
FY2024F
FY2025F
FY2026F
FY2027F
Hospitals Clinics Research Institutes Others
India mRNA Based Coronavirus Vaccine Market Share, By End User, By Value, FY2017-FY2027F

14. 14
Report Ordering
Report Name: INDIA CORONAVIRUS VACCINE MARKET
FORECAST & OPPORTUNITIES
FY2017 – FY2027
To View Sample OR Purchase Report
License Type Price
Single User License $3500
Multi-User License $4500
Custom Research License $7500

15. About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in
number of areas to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality
analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ model of a country, regional and global
company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.
Related Reports
• United States Hospital Market By Ownership (Public v/s Private) By Type (General, Specialty, Multi- Specialty) By Type of Services (In-Patient
Services v/s Out-Patient Services) By Bed Capacity (Up to 100 beds, 100-500 beds, Above 500 beds) By Region, Competition Forecast &
Opportunities, 2026
• India Insulin Delivery Devices Market By Product Type (Pens, Pumps, Pen Needles, Others) By Distribution Channel (Hospital Pharmacies, Retail
Pharmacies, Online, Others) By End User (Hospitals & Clinics, Homecare, Others) By Region, Competition Forecast & Opportunities, FY2027
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely,
accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it
considers reliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible
for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the
subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this
document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior
approval of TechSci Research.
TechSci Research – North America
708 Third Avenue, Manhattan,
New York, United States
Tel: +1- 646- 360- 1656
Email: sales@techsciresearch.com
www.techsciresearch.com
Disclaimer
TechSci Research – Europe
54, Old brook, Bretton,
Peterborough,
United Kingdom
Email: sales@techsciresearch.com
www.techsciresearch.com
TechSci Research – Asia-Pacific
B – 44, Sector – 57, Noida, National Capital
Region, U.P. - India
Tel: +91-120-4523900
Email: sales@techsciresearch.com
www.techsciresearch.com